Isolere is re-imagining how complex biologics can be manufactured more efficiently. To achieve this, we have combined two phenomena highly evolved by nature -- specific affinity binding and liquid-liquid phase separation. Our team of passionate and talented scientists are working to bring an adeno-associated virus (AAV) manufacturing technology--IsoTag AAV--to market. IsoTag promises to address today's major AAV production bottlenecks. Our mission is to revolutionize the bioprocessing industry, accelerate research and development timelines, and make life-changing cell and gene therapies more globally accessible.